Lyka Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE933A01014
  • NSEID: LYKALABS
  • BSEID: 500259
INR
44.95
-1.53 (-3.29%)
BSENSE

Mar 30

BSE+NSE Vol: 1.1 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 189121,
    "name": "Lyka Labs",
    "stock_name": "Lyka Labs",
    "full_name": "Lyka Labs Ltd",
    "name_url": "stocks-analysis/lyka-labs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "44.95",
    "chg": -1.53,
    "chgp": "-3.29%",
    "dir": -1,
    "prev_price": "46.48",
    "mcapval": "164.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 500259,
    "symbol": "LYKALABS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE933A01014",
    "curr_date": "Mar 30",
    "curr_time": "",
    "bse_nse_vol": "1.1 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 30, 2026",
    "traded_date_str": "2026 03 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lyka-labs-189121-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Markets Rally, But Lyka Labs Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs4455-amidst-continued-downtrend-3924025",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3924025.png",
        "date": "2026-03-30 09:50:41",
        "description": "Despite a broader market recovery, Lyka Labs Ltd has plunged to a fresh 52-week low of Rs 44.55 on 30 Mar 2026, marking a steep 53.37% decline over the past year and underscoring persistent headwinds for this micro-cap pharmaceutical player."
      },
      {
        "title": "Markets Rally, But Lyka Labs Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3919565",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3919565.png",
        "date": "2026-03-27 12:26:38",
        "description": "While broader indices showed signs of recovery, Lyka Labs Ltd plunged to a fresh 52-week low of Rs 47.3 on 27 Mar 2026, marking a steep decline of 7.74% intraday and underperforming its sector by over 7%. This drop extends the stock’s downward trajectory amid persistent financial headwinds and market scepticism."
      },
      {
        "title": "Markets Rally, But Lyka Labs Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs-477-amidst-continued-downtrend-3910879",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3910879.png",
        "date": "2026-03-24 15:40:14",
        "description": "Despite a broadly positive market environment, Lyka Labs Ltd has plunged to a fresh 52-week low of Rs 47.7 on 24 Mar 2026, extending its recent downward trajectory amid persistent headwinds."
      },
      {
        "title": "Lyka Labs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lyka-labs-ltd-is-rated-strong-sell-3909758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_mojoScore_3909758.png",
        "date": "2026-03-24 10:10:16",
        "description": "Lyka Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Five Consecutive Losses Push Lyka Labs Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs5009-amid-market-downturn-3907914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3907914.png",
        "date": "2026-03-23 12:55:13",
        "description": ""
      },
      {
        "title": "Lyka Labs Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3896662",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3896662.png",
        "date": "2026-03-17 11:45:33",
        "description": "Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.51.17 on 17 Mar 2026, marking a significant decline amid persistent underperformance and deteriorating financial metrics."
      },
      {
        "title": "Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.51.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs5145-3893415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3893415.png",
        "date": "2026-03-16 10:11:33",
        "description": "Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.51.45 today, marking a significant decline in its stock price amid ongoing financial and market pressures. This fresh low underscores the stock’s persistent underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.54 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs54-amid-continued-downtrend-3888420",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3888420.png",
        "date": "2026-03-13 09:42:58",
        "description": "Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.54 today, marking a significant decline amid ongoing market pressures and company-specific headwinds. The stock has underperformed its sector and benchmark indices, reflecting persistent challenges in its financial and technical performance."
      },
      {
        "title": "Lyka Labs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lyka-labs-ltd-is-rated-strong-sell-3886676",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_mojoScore_3886676.png",
        "date": "2026-03-12 10:10:34",
        "description": "Lyka Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 12 March 2026, providing investors with the latest comprehensive analysis."
      }
    ],
    "total": 402,
    "sid": "189121",
    "stock_news_url": "https://www.marketsmojo.com/news/lyka-labs-189121"
  },
  "announcements": [
    {
      "details": "Lyka Labs Limited Labs Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Lyka Labs Limited - Reply to Clarification- Financial results",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Lyka Labs Limited has informed the Exchange regarding Disclosure of Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Lyka Labs Limited - Other General Purpose",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Lyka Labs Limited has informed the Exchange regarding 'This is to inform pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, that the Company has entered into Loan Agreement with International Asset Reconstruction Company Private Limited (hereinafter referred to as IARC ).",
      "source": "NSE",
      "caption": "Lyka Labs Limited - Updates",
      "datetime": "22-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(31 Mar 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Lyka Labs Limited - Reply to Clarification- Financial results

03-Dec-2019 | Source : NSE

Lyka Labs Limited Labs Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Lyka Labs Limited - Other General Purpose

28-Nov-2019 | Source : NSE

Lyka Labs Limited has informed the Exchange regarding Disclosure of Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Lyka Labs Limited - Updates

22-Nov-2019 | Source : NSE

Lyka Labs Limited has informed the Exchange regarding 'This is to inform pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, that the Company has entered into Loan Agreement with International Asset Reconstruction Company Private Limited (hereinafter referred to as IARC ).

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(31 Mar 2026)

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available